Sarkar M, Madabhavi I
World J Methodol. 2024; 14(3):89761.
PMID: 39310238
PMC: 11230071.
DOI: 10.5662/wjm.v14.i3.89761.
Jin G, Wang R, Jin Y, Song Y, Wang T
Clin Transl Immunology. 2024; 13(5):e1514.
PMID: 38770238
PMC: 11103645.
DOI: 10.1002/cti2.1514.
Shahriarirad S, Asmarian N, Shahriarirad R, Moghadami M, Askarian M, Hashemizadeh Fard Haghighi L
Iran J Med Sci. 2024; 49(4):247-258.
PMID: 38680224
PMC: 11053253.
DOI: 10.30476/IJMS.2023.97708.2951.
Maniscalco L, Genovese D, Ravazzolo B, Vella G, Sparacia B, Vitale F
Vaccines (Basel). 2023; 11(12).
PMID: 38140163
PMC: 10748171.
DOI: 10.3390/vaccines11121757.
Nguyen N, Nguyen Y, Hoang V, Million M, Gautret P
Viruses. 2023; 15(4).
PMID: 37112949
PMC: 10145185.
DOI: 10.3390/v15040967.
Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19.
Valenzuela-Fernandez A, Cabrera-Rodriguez R, Ciuffreda L, Perez-Yanes S, Estevez-Herrera J, Gonzalez-Montelongo R
Front Bioeng Biotechnol. 2022; 10:1052436.
PMID: 36507266
PMC: 9732709.
DOI: 10.3389/fbioe.2022.1052436.
Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis.
Deng L, Li P, Zhang X, Jiang Q, Turner D, Zhou C
Sci Rep. 2022; 12(1):20763.
PMID: 36456577
PMC: 9714387.
DOI: 10.1038/s41598-022-24220-7.
SARS-CoV-2 coinfections with variant genomic lineages identified by multiplex fragment analysis.
Lueking R, Clark A, Narasimhan M, Mahimainathan L, Muthukumar A, Larsen C
Front Genet. 2022; 13:942713.
PMID: 36226173
PMC: 9549124.
DOI: 10.3389/fgene.2022.942713.
Reinfection and reactivation of SARS-CoV-2.
Dowran R, Rayati Damavandi A, Azad T
Future Virol. 2022; .
PMID: 36176508
PMC: 9514089.
DOI: 10.2217/fvl-2021-0212.
Recurrence of COVID-19 infection symptoms in short time; reinfection or reactivation? Three cases of three healthcare workers and a literature review.
Ahmed N, Abbas K, Makhoul E, Deeb R, Raya A, Khaddour N
Ann Med Surg (Lond). 2022; 82:104619.
PMID: 36117528
PMC: 9467930.
DOI: 10.1016/j.amsu.2022.104619.
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.
Marinov G, Mladenov M, Rangachev A, Alexiev I
PLoS One. 2022; 17(9):e0274509.
PMID: 36084070
PMC: 9462809.
DOI: 10.1371/journal.pone.0274509.
Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review.
Toro-Huamanchumo C, Hilario-Gomez M, Pinedo-Castillo L, Zumaran-Nunez C, Espinoza-Gonzales F, Caballero-Alvarado J
New Microbes New Infect. 2022; 48:101021.
PMID: 36060548
PMC: 9420201.
DOI: 10.1016/j.nmni.2022.101021.
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines.
Abdolmaleki G, Taheri M, Paridehpour S, Mohammadi N, Tabatabaei Y, Mousavi T
Daru. 2022; 30(2):379-406.
PMID: 36050585
PMC: 9436716.
DOI: 10.1007/s40199-022-00446-8.
Features of antibody responses after SARS-COV-2 infection in healthcare workers in the first wave of COVID-19 pandemic in Mexico City.
Thompson-Bonilla M, Leon J, Cardenas-Turrent M, Pena-Thompson A, Hanessian-De la Garza D, Zavala-Vega S
J Int Med Res. 2022; 50(7):3000605221099458.
PMID: 35879824
PMC: 9340344.
DOI: 10.1177/03000605221099458.
SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
Al-Otaiby M, Krissaane I, Al Seraihi A, Alshenaifi J, Qahtani M, Aljeri T
Int J Infect Dis. 2022; 122:758-766.
PMID: 35840098
PMC: 9364818.
DOI: 10.1016/j.ijid.2022.07.025.
Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol.
Wallace S, Hall V, Charlett A, Kirwan P, Cole M, Gillson N
BMJ Open. 2022; 12(6):e054336.
PMID: 35768083
PMC: 9240450.
DOI: 10.1136/bmjopen-2021-054336.
COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants.
Stefanelli P, Rezza G
Vaccines (Basel). 2022; 10(6).
PMID: 35746513
PMC: 9229267.
DOI: 10.3390/vaccines10060905.
IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes.
Garrido J, Medina M, Bravo F, McGee S, Fuentes-Villalobos F, Calvo M
Cell Rep. 2022; 39(9):110904.
PMID: 35617962
PMC: 9108089.
DOI: 10.1016/j.celrep.2022.110904.
First Identification of Reinfection by a Genetically Different Variant of SARS-CoV-2 in a Homeless Person from the Metropolitan Area of Santiago, Chile.
Acuna-Castillo C, Vidal M, Inostroza-Molina A, Vallejos-Vidal E, Luraschi R, Figueroa M
J Environ Public Health. 2022; 2022:3859071.
PMID: 35528635
PMC: 9068328.
DOI: 10.1155/2022/3859071.
Reinfection in patients with COVID-19: a systematic review.
Ren X, Zhou J, Guo J, Hao C, Zheng M, Zhang R
Glob Health Res Policy. 2022; 7(1):12.
PMID: 35488305
PMC: 9051013.
DOI: 10.1186/s41256-022-00245-3.